Marcella V. Catania

Via Celoria 11
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study.

Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study.

Journal: International journal of molecular sciences

Published: April 08, 2026

Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients.

Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients.

Journal: Parkinsonism & related disorders

Published: March 04, 2026

PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction.

PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction.

Journal: Pharmacological research

Published: December 23, 2025

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Journal: Acta neuropathologica

Published: September 16, 2025

Detection of TDP-43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS.

Detection of TDP-43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 11, 2025

The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies.

The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies.

Journal: Pharmacological research

Published: October 14, 2024

TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis.

TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis.

Journal: Molecular neurodegeneration

Published: October 01, 2024

CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy.

CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy.

Journal: Neurology

Published: September 16, 2024

Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform.

Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform.

Journal: Fluids and barriers of the CNS

Published: August 14, 2024

Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.

Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.

Journal: International journal of molecular sciences

Published: December 12, 2023

Myoclonus in genetic Alzheimer's disease due to presenilin-1 mutation.

Myoclonus in genetic Alzheimer's disease due to presenilin-1 mutation.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: September 30, 2023

Rare causes of dystonia-parkinsonism with cognitive impairment, behavioral abnormalities, and voiceless whispering stereotypies: Describing the long-term evolution of the neurological phenotype in a patient with the PSEN2 Ile149Thr variant.

Rare causes of dystonia-parkinsonism with cognitive impairment, behavioral abnormalities, and voiceless whispering stereotypies: Describing the long-term evolution of the neurological phenotype in a patient with the PSEN2 Ile149Thr variant.

Journal: Journal of the neurological sciences

Published: September 05, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026